Skip to main content
Log in

Inhibition of intraocular proliferation by homoharringtonine

An experimental study

  • Laboratory Investigations
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Homoharringtonine, an alkaloid indigenous to China, was studied for its effect on fibroblast growth in cell culture and on intraocular proliferation produced in rabbits by injecting homologous fibroblasts into the vitreous. The results demonstrate that homoharringtonine reduced the cell growth by 50% at a concentration of 0.005 mg/l in vitro, significantly inhibited vitreous proliferation, and prevented the occurrence of retinal detachment in vivo. Light and electron microscopy revealed no ocular toxicity in drug-treated eyes. Homoharringtonine may be of considerable value in the prevention and treatment of intraocular proliferation in patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Avni I, Belkin M, Hereberg A, Blumenthal M (1984) Intravitreal 5-fluorouracil in the prevention of post-traumatic vitreous proliferation. Ophthalmologica 188:5–8

    Google Scholar 

  2. Binder S, Riss B, Skorpik C, Kulnig W (1983) Inhibition of experimental intraocular proliferation with intravitreal 5-fluouracil. Graefe's Arch Clin Exp Ophthalmol 221: 126–129

    Google Scholar 

  3. Blumenkranz MS, Claflin A, Hajek AS (1984) Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch Ophthalmol 102:598–607

    Google Scholar 

  4. Bockxmeer FM van, Martin CE, Constable IJ (1985) Models for assessing scar tissue inhibitors. Retina 5:47–60

    Google Scholar 

  5. Bockxmeer FM van, Martin CE, Thompson DE, Constable IJ (1985) Taxol for the treatment of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26:1140–1147

    Google Scholar 

  6. Faulborn J, Topping TM (1978) proliferations in the vitreous cavity after perforating injuries. A histopathological study. Graefe's Arch Clin Exp Ophthalmol 205:157–166

    Google Scholar 

  7. Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing (1979) Chemical, pharmacological and clinical studies on the antitumor active principle ofCephalotaxus hainanensis Li. Chin J Oncol 1: 176–181 (in Chinese)

    Google Scholar 

  8. Tano Y, Chandler D, Machemer R (1980) Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 90:810–816

    Google Scholar 

  9. Wiedemann P, Kirmani M, Sorgente N, Ryan SJ (1983) Control of experimental massive periretinal proliferation by daunomycin: dose-response relation. Graefe's Arch Clin Exp Ophthalmol 220:233–235

    Google Scholar 

  10. Wiedemann P, Sorgente N, Bekhor C, Patterson R, Tran T, Ryan SJ (1985) Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26:719–725

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported by The National Science Fund

Rights and permissions

Reprints and permissions

About this article

Cite this article

Junping, L., Chunzhi, H., Shuiqing, Z. et al. Inhibition of intraocular proliferation by homoharringtonine. Graefe's Arch Clin Exp Ophthalmol 226, 367–370 (1988). https://doi.org/10.1007/BF02172969

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02172969

Keywords

Navigation